**Kingswood Wealth Advisors LLC Reduces Stake in SPDR S&P Biotech ETF
In a strategic move during the fourth quarter, Kingswood Wealth Advisors LLC adjusted its investment portfolio by decreasing its position in the SPDR S&P Biotech ETF (NYSEARCA: XBI) by 7.4%. The firm sold off 465 shares, bringing its total holdings to 5,850 shares, valued at approximately $522,000, according to the most recent SEC filing.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
